PharmExec Direct: Having trouble viewing the email? Click Here

In this ISSUE

Is the Hatch-Waxman System Broken?

FDA Drug Approvals 2015

Rough Road Ahead for Innovation

Advertisement
From the Editor
2016: A Biopharma Market in Flux
William Looney
Pharm Exec Editor-in-Chief William Looney offers his take on the opportunities, threats, and other big issues facing the industry in the new year.
... /Read more/

Event
An Eye on the J.P. Morgan Healthcare Conference 2016
Just because you weren't able to make the trip this week doesn’t mean you can't stay current on the news coming out of the Westin St. Francis Hotel, San Francisco. Casey McDonald keeps an eye on the tweets coming from one of the healthcare industry’s biggest events
... /Read more/
Marketing
Feel the Earth Move under Your Brand?
Al Topin lists the “seven significants” for brand planning in 2016 that pose the best chance for stable footing amid the seismic state of today's ever-changing healthcare landscape
... /Read more/
Europe
NHS: Evaluating Innovation, Health and Wealth
Will the UK learn from past efforts to champion innovation in the NHS? Leela Barham assesses the Phase 1 evaluation, published this week, of the NHS's Innovation, Health and Wealth initiative
... /Read more/
Calendar
/ January 28–29, 2016: 11th Summit on Biosimilars/
Alexandria, VA.
/ February 18–19, 2016: Bio/Pharma Social Media and Digital Platforms/
Philadelphia, PA.
/ February 23–24, 2016: Speaker Programs 2016/
Philadelphia, PA.
/ March 15–17: eyeforpharma 2016/
Barcelona, Spain
/ April 7–8: Global Transparency Reporting Congress/
Frankfurt, Germany
 
Industry update
//Elite Pharmaceuticals (Northvale, NJ) announced that Jerry Treppel has resigned as the company's Chairman and as a member of the Board of Directors to pursue other opportunities. Nasrat Hakim, Elite's President and CEO, has been elected to serve as Chairman of the Board.//Crown Bioscience (Santa Clara, CA) named Eric Murphy, Ph.D., as Global Scientific Director for Translational Oncology.//
NewLink Genetics (Ames, IA) appointed Brian Wiley as Chief Commercial Officer.//Zosano Pharma (Fremont, CA) announced the appointment of Konstantinos Alataris, Ph.D. as President and Chief Executive Officer.//
Advertisement
advertise with us / print subscribe / digital subscribe / visit pharmexec.com